Boston Scientific lands at Teterboro after a week of major deal-making

Boston Scientific flew from Sids Airport in Massachusetts to Teterboro Airport in New Jersey on May 26, a 55-minute hop in its Challenger 650, tail N650BS. The short trip from a small airfield near the company’s Marlborough headquarters to the New York metro area is a familiar route for the medical device maker’s executives.

The same week, Boston Scientific announced a $1.5 billion investment in MiRus LLC for a 34% equity stake and an exclusive option to acquire the company’s SIEGEL balloon-expandable TAVR system, per a May 18 press release on the company’s news site. The deal, which includes potential future payments totaling $3 billion, signals a major push into the transcatheter aortic valve replacement market. The company also entered into a $2 billion accelerated share repurchase agreement on the same day, as noted in a separate release.

Teterboro is a common gateway for Boston Scientific’s leadership to meet with investors, analysts, or partners in the New York area. The flight pattern shows frequent shuttles between Boston-area airports and Teterboro, including trips on May 7 and May 16, suggesting routine business travel rather than a one-off event. This visit likely continues discussions around the MiRus deal or other portfolio moves.